Clinical Trial Update: EARly Prevention of aTHeroma Progression [Phase 4]

View source ↗

Summary

A Phase 4 trial aiming to prevent atheroma progression in coronary arteriosclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis

Snippet

Sponsor: CHEOL WHAN LEE, M.D., Ph.D | Conditions: Coronary Arteriosclerosis | Phase 4 | Status: TERMINATED